back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-03 12:16 Tx date 2024-04-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+12,500 vol |
161,271 | |
| Filed 2024-04-03 12:13 Tx date 2024-04-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+12,500 vol |
||
| Filed 2024-03-29 16:48 Tx date 2024-03-26 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-152,345.6675
-13,975 vol $10.90 each |
148,771 | |
| Filed 2024-03-29 16:47 Tx date 2024-03-25 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-153,690.0625
-13,975 vol $11.00 each |
162,746 | |
| Filed 2023-07-05 16:37 Tx date 2023-06-30 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-66,150
-7,500 vol $8.82 each |
176,721 | |
| Filed 2023-07-05 16:36 Tx date 2023-06-30 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-67,275
-7,500 vol $8.97 each |
184,221 | |
| Filed 2023-07-05 16:35 Tx date 2023-06-30 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-89,900
-10,000 vol $8.99 each |
191,721 | |
| Filed 2023-07-05 16:35 Tx date 2023-06-30 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$61,250
+25,000 vol $2.45 each |
201,721 | |
| Filed 2023-07-05 16:32 Tx date 2023-06-30 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-61,250
-25,000 vol $2.45 each |
680,000 | |
| Filed 2023-04-28 16:58 Tx date 2023-04-28 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$624,000
+75,000 vol $8.32 each |
705,000 | |
| Filed 2023-04-04 08:49 Tx date 2023-03-31 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$624,083
+75,010 vol $8.32 each |
630,000 | |
| Filed 2022-09-22 11:51 Tx date 2022-09-21 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-162,704.08
-19,052 vol $8.54 each |
176,721 | |
| Filed 2021-12-20 17:53 Tx date 2021-12-20 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+37,500 vol |
195,773 | |
| Filed 2021-12-20 17:30 Tx date 2015-11-12 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-20 17:29 Tx date 2015-11-12 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-20 17:27 Tx date 2015-11-12 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-20 17:19 Tx date 2015-11-12 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-20 17:15 Tx date 2021-12-20 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$306,000
+75,000 vol $4.08 each |
554,990 | |
| Filed 2021-06-03 08:45 Tx date 2021-06-02 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$753,000
+100,000 vol $7.53 each |
479,990 | |
| Filed 2020-08-17 16:44 Tx date 2020-08-17 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-73,510.54
-12,874 vol $5.71 each |
158,273 | |
| Filed 2020-08-17 16:43 Tx date 2020-08-14 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-220,952
-38,900 vol $5.68 each |
171,147 | |
| Filed 2020-08-17 16:41 Tx date 2020-08-13 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-224,037.56
-38,828 vol $5.77 each |
210,047 | |
| Filed 2020-08-17 16:39 Tx date 2020-08-13 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-599,329.12
-97,136 vol $6.17 each |
248,875 | |
| Filed 2020-08-17 16:38 Tx date 2020-08-13 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$599,327
+323,961 vol $1.85 each |
346,011 | |
| Filed 2020-08-14 08:02 Tx date 2020-08-13 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-764,547.96
-323,961 vol $2.36 each |
379,990 | |
| Filed 2020-05-15 17:47 Tx date 2020-05-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$866,250
+125,000 vol $6.93 each |
703,951 | |
| Filed 2019-04-06 09:54 Tx date 2019-04-04 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$386,400
+80,000 vol $4.83 each |
578,951 | |
| Filed 2018-08-17 Tx date 2018-08-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,552
-17,050 vol $1.44 each |
498,951 | |
| Filed 2018-08-17 Tx date 2018-08-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,552
+17,050 vol $1.44 each |
22,050 | |
| Filed 2018-02-07 Tx date 2018-02-06 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$419,000
+50,000 vol $8.38 each |
516,001 | |
| Filed 2017-06-28 Tx date 2017-06-27 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$254,999
+50,000 vol $5.10 each |
466,001 | |
| Filed 2016-07-08 Tx date 2016-07-05 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$183,750
+75,000 vol $2.45 each |
416,001 | |
| Filed 2015-11-19 Tx date 2015-11-12 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
700,000 | ||
| Filed 2015-11-18 Tx date 2015-11-12 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
341,001 | ||
| Filed 2015-11-18 Tx date 2015-11-12 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,000 |